We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Wristwatch-Like Device Automates Drug Delivery

By Biotechdaily staff writers
Posted on 27 Sep 2004
A new drug delivery device, worn like a wristwatch, can be programmed to administer drug doses into the body automatically, at different times of the day and in varying doses, whether the patient is asleep or awake.

Called ChronoDose, the system is most effective for treating heart disease, depression, asthma, attention-deficit disorder, hypertension, and arthritis, according to the marketer, Chrono Therapeutics, Inc. More...
(Nanuet, NY, USA). The device can be programmed to release drugs when disease symptoms are statistically worst, to increase the effectiveness of therapy. The device is capable of precisely tailored drug delivery where noninvasive, automated administration of a precise drug at a precise time was previously impossible.

ChronoDose was developed by the University of Basel, the University of Applied Science of Basel, and the University of Applied Science of Solothurn (all in Switzerland) in association with Chrono Therapeutics.

Our ChronoDose system will help ease patient suffering by managing peak disease symptoms with far greater efficacy and fewer side effects than any other system available today, noted Guy DiPierro, founder and president of Chrono Therapeutics.


Related Links:
Chrono Therapeutics

Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
Prefilled Tubes
Prefilled 5.0ml Tubes
New
Benchtop Thermomixer
Biometra TS1 ThermoShaker
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.